Background-The contribution of heart failure (HF) unrelated to vascular disease to the overall HF burden in older adults is not well characterized.
According to a recent American Heart Association policy statement, the proportional increase in HF over the next two decades will be more than any other major cardiovascular condition, which will translate into a 215% increase in direct medical costs of care by 2030. 16 In older adults, HF may develop due to age-related cardiac changes, or other comorbidities, that may or may not be related to at least manifest CAD. 17 Cardiovascular fibrotic changes and structural remodeling related to hypertension, diabetes, renal dysfunction, and obesity, may all cause HF in the absence of clinical CAD. 17, 18 Beyond increased prevalence of cardiometabolic risk factors, older adults demonstrate higher levels of low-grade inflammation, 19 endothelial dysfunction, 20 and higher prevalence of atrial fibrillation. 21 These age-related changes can contribute to development of manifest HF independent of intervening CAD. [22] [23] [24] The risk related to these risk factors may be lessened with generic prevention interventions e.g. lifestyle choices. More targeted efforts focused on interstitial matrix remodeling may provide alternate unexplored means to prevent HF in older adults. Such targeted interventions may not be warranted, however, if indeed most HF was truly preceded by CAD, in which case the current prevention focus on vascular disease should suffice.
There is a paucity of information on reliable population-based estimates of HF epidemiology in relation to vascular disease in older adults. [25] [26] [27] To address this issue, we studied the data on the participants of the Health Aging and Body Composition (Health ABC) Study. 28 
Methods

Study Population
The Health ABC Study enrolled 3075 well-functioning, community dwelling adults aged 70 to 79 years between April 1997 and June 1998. Participants were identified from a random sample of white Medicare beneficiaries and all age-eligible black community residents in designated zip code areas surrounding Pittsburgh, PA and Memphis, TN. Exclusion criteria included difficulties with activities of daily living, obvious cognitive impairment, inability to communicate, anticipated move within 3 years, or participation in a trial involving lifestyle intervention. The institutional review boards at both study sites approved the protocol. Participants with known or missing HF status at baseline (N=140) and those with information missing on preceding vascular disease (N=40) were excluded from the analysis. The final cohort analyzed for this study included 2895 participants.
Study Outcomes
All participants were asked to report any hospitalizations and every 6 months were asked direct questions about interim events. Medical records for overnight hospitalizations were reviewed at each site. All first admissions with an overnight stay that was confirmed as related to HF were classified as incident HF. HF diagnosis was adjudicated based on symptoms, signs, chest radiograph results, and echocardiographic findings, using criteria similar to those used in the Cardiovascular Health Study. 29 The criteria required at least HF diagnosis from a physician and treatment for HF. 30 In addition data on left ventricular ejection fraction during the index HF hospitalization was available in subset of HF cases. All deaths were reviewed by the Health ABC Study diagnosis and disease ascertainment committee and underlying causes of death were determined by central adjudication.
Study Definitions
Race was self-defined by the participant. Hypertension was defined as self-reported history of physician diagnosis accompanied by use of antihypertensive medications. Diabetes mellitus was considered present if the participant reported a history of diabetes mellitus or use of anti-hyperglycemic medication. Smoking was defined as current, past (≥100 lifetime cigarettes), or never. Left ventricular hypertrophy was diagnosed based on the following criteria; R amplitude >26 mm in either V5 or V6, or >20 mm in any of leads I, II, III, aVF, or >12 mm in lead aVL or R in V5 or V6 plus S amplitude in V1 >35 mm. Left ventricular ejection fraction (LVEF) was defined as preserved if ≥ 40%or reduced if <40.
Prevalent CAD was defined as: (1) history of surgical or percutaneous revascularization; or (2) electrocardiographic evidence of myocardial infarction; or (3) self-reported history of myocardial infarction or angina accompanied by use of antianginal medications. Incident CAD was defined as hospitalization for myocardial infarction or angina pectoris, or elective revascularization. Prevalent vascular disease was defined as prevalent: (1) CAD; (2) cerebrovascular disease (history of stroke, transient ischemic attack, or carotid endarterectomy); or (3) PVD (history of intermittent claudication or vascular bypass or angioplasty). 31, 32 Incident vascular disease was defined as incident (1) CAD; (2) cerebrovascular disease (stroke, transient ischemic attack, or symptomatic carotid artery disease); (3) PVD; or (4) death due to cardiovascular causes. Participants were classified as having "preceding CAD" if they had prevalent CAD at baseline or developed incident CAD that preceded or coincided with the onset of HF. Individuals were classified as having "preceding vascular disease" if they had prevalent CAD, cerebrovascular disease, or PVD at baseline or developed incident CAD, or cerebrovascular disease, or PVD that preceded or coincided with the onset of HF.
Risk Factors for Incident HF
We have previously reported independent predictors of incident HF in the Health ABC Study, including age, history of smoking, coronary heart disease, left ventricular hypertrophy, systolic blood pressure, heart rate, serum glucose, albumin, and creatinine levels. 14, 28, 33 The association of these risk factors with risk of HF was assessed in both those with and without prior vascular disease.
Statistical Analysis
The baseline characteristics were compared in individuals with and without incident HF. Individual participant characteristics were also compared in those who develop HF with and without preceding vascular disease. Continuous variables were compared using the t-test and categorical variables with the chi-square test. Cumulative event rates were obtained with the Kaplan-Meier method and compared with the log-rank statistic. Time-to-event analyses were conducted using Cox proportional hazard models. The proportional hazards assumption was evaluated by examining the Schoenfeld residuals. To assess the association of established risk factors as identified in the Health ABC HF Risk Score (age, history of smoking, coronary heart disease, left ventricular hypertrophy, systolic blood pressure, heart rate, serum glucose, albumin, and creatinine levels) 14, 27, 28, 33 with HF in participants with vs. without baseline vascular disease, multivariable hazard ratios (HR) adjusted for gender were calculated. All-cause and HF-related hospitalizations post-HF development were analyzed as count data over time at risk. Hospitalization rates and rate ratios (RR) with 95% confidence intervals (CI) were obtained by Poisson regression model for participants who developed HF with vs. without preceding vascular disease, adjusted for age and gender. In a secondary analysis, we examined post HF outcomes in a subset of participants with LVEF available at the time of incident HF, categorized as preserved (≥40%) or reduced (<40). All analyses were performed using Stata release 11 (Stata Corp LP, College Station, Texas). glucose levels, and lower high-density lipoprotein cholesterol levels were observed in participants who developed HF with preceding vascular disease only.
Incident Heart Failure
After median follow-up of 11.4 (interquartile range [IQR] 7.0, 11.7) years, 493 participants (16.8%) developed HF (annual rate 18.1/1000 person-years, 95%CI 16.5, 19.7). Among those participants who developed HF, 211 (42.8%) had prevalent vascular disease, 72 (14.6%) developed incident vascular disease before HF onset, 64 (13.0%) developed HF simultaneously with a vascular event, and 7 (1.4%) had missing information on vascular disease, and were subsequently dropped from further analysis. Overall, 134 (27.2%) participants developed HF without preceding or concomitant vascular event ( Figure 1a ) and 177 (36.8%) without preceding CAD (Figure 1b ).
Incidence of HF increased progressively across age groups, both for those with (P=0.03) and without a preceding vascular event (P<0.001), Figure 2 . Gender and race related incident HF event rates stratified by preceding vascular disease are shown in Table 2 and Figure 3 . Blacks were more likely to develop HF than whites with preceding vascular disease (stratified log-rank χ2 for race 4.21, P=0.04), but not without preceding vascular disease (stratified log-rank χ2 for race 2.48, P=0.11).
Heart Failure Risk Factors
All Health ABC HF Risk Model variables (age, albumin, creatinine, heart rate, fasting glucose, left ventricular hypertrophy, systolic blood pressure, and smoking) were independently associated with HF in those with and without preceding vascular disease at baseline, Table 3 Systolic blood pressure and heart rate were more strongly associated with HF in those without preceding vascular disease (interaction P<0.05) in blacks. Both baseline (HR 2.4, 95% CI 1.9, 2.8) and incident (HR 4.3, 95%CI 3.6, 5.2) vascular disease was associated with HF.
Outcomes after Heart Failure Development
Participants who remained free of HF had an annual mortality of 4.2% (95%CI 3.9, 4.5) and an all cause hospitalization rate of 23.9 admissions per 1000 person-years. During a median follow-up of 2.1 (IQR 0.4, 5.1) years after HF onset, 67.5% participants died. Annual mortality was 21.3% (18.8, 24. 2) after HF development in those with preceding vascular disease and 24.6% (19.9, 30.4) in those without vascular disease (HR 1.11, 95%CI 0.87, 1.43; P=0.399). Figure 4 
Preserved vs. Reduced Ejection Fraction
Data on left ventricular ejection fraction during the index HF hospitalization was available in 381 (77.3%) participants. The ejection fraction median was 42%, IQR 30%-55%. Median ejection fraction was lower in those with than those without preceding vascular disease (40% vs. 50% respectively, P<0.030). Proportion of participants with reduced versus preserved left ventricular ejection fraction was 45.0% and 55.0% for those with preceding vascular disease and 33.0% vs. 67.0% for those without preceding vascular disease (P=0.040). Mortality and hospitalization risk was higher among participants with reduced ejection fraction versus preserved ejection fraction for participants with preceding vascular disease (HR 1. 
Discussion
In this study, consistent with previous reports, we found that vascular disease was an independent predictor of HF in older adults and that the majority of incident cases occurred among individuals with some form of vascular disease 34, 35 . However, over a quarter of HF cases were not preceded by a vascular event and one third of cases developed among participants without clinically manifest CAD. These proportions represent a relatively large segment of the at-risk HF population that would be overlooked by the current cardiovascular disease prediction and prevention strategies focusing either specifically on CAD or vascular disease in general.
As the proportion of older individuals in the population increases, the prevalence of HF is predicted to increase substantially. 36, 37 Older individuals are more likely than younger people to develop HF, especially HF with preserved ejection fraction (HFpEF), due to increasing prevalence of cardiometabolic risk factors with ageing and age-related cardiac structural and functional changes. Our data are consistent with this finding that participants without preceding vascular disease were particularly prone to HFpEF. Beyond increased prevalence of hypertension, diabetes, obesity, and renal dysfunction, all of which can lead to cardiomyopathic changes and exert direct negative effects on the myocardium without preceding CAD, older adults demonstrate higher levels of low-grade inflammation. 19 In cohort studies, inflammation has been demonstrated to contribute to development of HF, 22 potentially through altered response to stressors, enhanced extracellular matrix remodeling, direct effects on the myocardium, and functional vascular changes (increased vascular stiffness and endothelial dysfunction) even without overt vascular disease. 38 In addition, endothelial function worsens with ageing 20 and has been demonstrated to contribute to development of HF independently of traditional risk factors. 23, 39 Finally, the incidence and prevalence of atrial fibrillation is increasing with age 21 and this may further precipitate clinical HF in older adults with stiffer left ventricles. 24 Therefore, as the population ages, it is expected that the proportion of HF not associated with vascular disease will increase, which in turn will continue to increase the proportion of HFpEF in the general population. These trends are confirmed by recent community based observational study and by registries, showing the increases in hospitalization of patients with HFpEF compared to HF with reduced ejection fraction (HFrEF). 40 Participants who develop HF without preceding vascular disease are at similar risk for adverse outcomes as compared to those with vascular disease, underscoring the clinical importance of this entity. Participants who developed HF without preceding vascular disease had significantly higher readmission risk than age-matched older adults without HF, and this risk was comparable to those who developed HF with preceding vascular disease. This is consistent with previous reports indicating that patients with HFpEF, which is less likely to be related to previous vascular disease, have similar event rates compared to HFrEF patients. In agreement with previous data patients with HFpEF may be more likely to survive HF hospitalization than those with HFrEF, even though they have equally high rates of readmission. 41 In our study, those participants developing HF without preceding vascular disease were more likely to be older, had higher systolic blood pressure, heart rate and body mass index. However, these characteristics were common among those with a history of vascular disease preceding development of HF as well. While those with a history of vascular disease preceding development of HF had a higher prevalence of diabetes, other risk factors, such as hypertension were similar between the two groups. This is also consistent with previous reports indicating that those with HFpEF are more likely to be older and have a history of hypertension.
There may be physiologic mechanisms specific to development of HF in older people unrelated to vascular disease. For example, more collagen is deposited in the ventricles with aging. 42, 43 This may be related to the aging process per se or could be secondary to common co-morbidities such as diabetes and hypertension. 44, 45 Future research is needed to determine the mechanisms relevant to HF development among the elderly beyond that which can be attributed to vascular disease. In addition targeted risk prediction models are needed for HF in the elderly or HF may be including in pan-cardiovascular risk prediction models, to aid in risk stratification for HF, especially among the elderly.
Our study has several limitations. The diagnosis of incident HF was based on HF hospitalization and therefore likely underestimated the true incidence. The Health ABC Study did not record data on atrial fibrillation and did not perform echocardiograms at baseline, and therefore no data on asymptomatic left ventricular dysfunction or atrial fibrillation in our cohort. However, since prediction and prevention strategies are targeted mostly to clinically manifest HF, this limitation does not minimize the importance of our results. The incidence of asymptomatic left ventricular dysfunction in previous communitybased epidemiologic studies was very low. 46, 47 In addition, this is consistent with coronary disease risk prediction and prevention strategies, e.g. in such studies, patients do not routinely undergo left heart catheterization or carotid or peripheral angiography to rule out asymptomatic coronary artery or other vascular disease, and the focus is on clinically manifest vascular or coronary disease. Nevertheless future studies must address the incidence of HF in relation to unrecognized CAD, which is an important clinical entity in the elderly and is associated with increased mortality. 48 In conclusion, the present study underscores the importance of vascular disease in relation to risk of HF but also reaffirms the existence of an important yet largely ignored clinical entity of HF without preceding vascular disease. Integrating incident HF into cardiovascular disease risk prediction and prevention strategies should be considered. Targeted HF prevention strategies may be beneficial at the population level and need further study. Incident heart failure events stratified by vascular disease 
